NCT03513393View on ClinicalTrials.gov

Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

December 1, 2018

Study Completion Date

December 1, 2018

Conditions
Hepatitis CSwallowing Disorder
Interventions
DRUG

velpatasvir

Test 1

DRUG

velpatasvir

Test 2

DRUG

velpatasvir

Reference

Trial Locations (1)

6525 GA

Radboud university medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT03513393 - Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole. | Biotech Hunter | Biotech Hunter